Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2026
- #956
- Final score
- 14.26
- Years on list
- 2
↗ Climbed 17 since 2025
Compare · Up to four Russell 1000 companies
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
Figure 01 · Side-by-side summary
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 17 since 2025
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 17 since 2025
Pharmaceuticals, Biotechnology & Life Sciences
↘ Down 446 since 2025
Figure 02 · Rank trajectory
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2026
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | RVMD | SMMT | TEM |
|---|---|---|---|
| Climate Change | 17.8 | 18.8 | 15.8 |
| Employee Relations | 14.1 | 9.5 | 14.5 |
| Environment | 6.5 | 5.5 | 2.3 |
| Stakeholders & Society | 11.5 | 18.0 | 14.5 |
| Human Rights | 4.7 | 2.5 | 11.3 |
| Governance | 26.7 | 25.4 | 21.2 |
| Performance Rating | 37.9 | 51.4 | 44.3 |